Stephan W. Morris

Fusion of a Kinase Gene, <i>ALK</i> , to a Nucleolar Protein Gene, <i>NPM</i> , in Non-Hodgkin's Lymphoma

Stephan W. Morris, Mark N. Kirstein, Marcus B. Valentine et al. · Science · 1994 · 2.4K citations

Activating mutations in ALK provide a therapeutic target in neuroblastoma

Rani E. George, Takaomi Sanda, Megan Hanna et al. · Nature · 2008 · 885 citations · Full text

Receptor Tyrosine Kinase, Tumor Suppressor, Radiation Oncology +4

Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1

Karen Pulford, Laurence Lamant, Stephan W. Morris et al. · Blood · 1997 · 566 citations

Anaplastic Lymphoma Kinase (ALK) Expression in the Inflammatory Myofibroblastic Tumor

James Cook, Louis P. Dehner, Margaret H. Collins et al. · The American Journal of Surgical Pathology · 2001 · 554 citations

Tumor Biology, Lymphoid Neoplasia, Tumoral Pathology +14

ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)

Stephan W. Morris, Clayton W. Naeve, Prasad Mathew et al. · Oncogene · 1997 · 526 citations

Gene Locus, Lymphoid Neoplasia, Signal Transduction +11